Login Register Cart 0
Generic placeholder image

Central Nervous System Agents in Medicinal Chemistry

Editor-in-Chief

ISSN (Print): 1871-5249
ISSN (Online): 1875-6166

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Synthesis, Computational and Pharmacological Evaluation of 7-(2-(2- (3- (Substituted Phenyl) Acryloyl) Phenoxy) Ethoxy)-4-Methyl-2H-Chromen- 2-Ones as CNS Agents

Author(s): Sushil Kumar* and Amit Kumar

Volume 23, Issue 1, 2023

Published on: 15 March, 2023

Page: [57 - 64] Pages: 8

DOI: 10.2174/1871524923666230130134501

Price: $65

Abstract

Background: Motivated by the exciting biological potential for the use of hybrid molecules in medicine and therapy. It is anticipated that the coumarin-chalcone hybrids for skeletal muscle and antianxiety action will be investigated using a chemical hybridization technique.

Objective: Due to its numerous benefits, including high effectiveness, mode of action at receptors, minimal adverse effects, and improved pharmacokinetic features, naturally occurring and synthesized hybrid compounds are prospective sources for novel drug development techniques. In opinion of these applications, we here designed some coumarin-chalcone hybrids and explored them for skeletal muscle and antianxiety potential.

Methods: Using a chemical hybridization strategy, coumarin-chalcone hybrids have been synthesized and evaluated for skeletal muscle and antianxiety activity. The target compounds were synthesized by reaction of 7-hydroxy-4-methylcoumarion with haloalkane to afford 7-(2- bromoethoxy)-4-methyl-2H-chromen-2-one which was further treated with hydroxychalcones. The structures of target compounds were confirmed on the basis of their Melting Point, Thin Layer Chromatography, IR, 1HNMR and Mass studies. The computational properties of target compounds were also determined through online software. Skeletal muscle and antianxiety potential were performed in Swiss albino mice.

Results: The coumarin-chalcones hybrids showed skeletal muscle and antianxiety potential in Swiss albino mice and computational properties of the target compounds were also showed similarity as compared with diazepam.

Conclusion: Among the target compounds, the fluoro group containing compound was found to be more potent as compared to the standard drug diazepam.

« Previous Next »
Graphical Abstract

[1]
Wei, H.; Ruan, J.; Zhang, X. Coumarin-Chalcone Hybrids: Promising agents with diverse pharmacological properties. J. RSC Adv., 2016, 47(12), 10846-10860.
[2]
Pasricha, S.; Gahlot, P. Synthetic strategies and biological potential of coumarin-chalcone hybrids: a new dimension to drug design. Curr. Org. Chem., 2020, 24(4), 402-438.
[http://dx.doi.org/10.2174/1385272824666200219091830]
[3]
Kumar, A.; Kumar, S. Coumarin-chalcone hybrids for biological potentials: A strategy of molecular hybridization for drug design. Int. J. Pharm. Sci. Rev. Res., 2020, 64(2), 146-151.
[http://dx.doi.org/10.47583/ijpsrr.2020.v64i02.024]
[4]
Hany, A.; El-Sherief, G.; El-Din, A.; Abuo, R.; Eman, A.; Beshr, M.E.S. Design and synthesis of new coumarin–chalcone/NO hybrids of potential biological activity. Med. Chem. Res., 2017, 26(12), 1-14.
[5]
Ratchanok, P.; Amporn, S.; Prasit, M.; Chanin, N.; Supaluk, P.; Somsak, R.; Virapong, P. Synthesis, biological evaluation and molecular docking of novel chalcone-coumarin hybrids as anticancer and antimalarial Agents. Eur. J. Med. Chem., 2014, 6(85), 65-76.
[6]
Mazzone, G.; Malaj, N.; Galano, A.; Russo, N.; Toscano, M. Antioxidant properties of several coumarin–chalcone hybrids from theoretical insights. RSC Advances, 2015, 5(1), 565-575.
[http://dx.doi.org/10.1039/C4RA11733F]
[7]
Feng, D.; Zhang, A.; Yang, Y.; Yang, P. Coumarin‐containing hybrids and their antibacterial activities. Arch. Pharm. (Weinheim), 2020, 353(6), 1900380.
[http://dx.doi.org/10.1002/ardp.201900380] [PMID: 32253782]
[8]
Skalicka-Woźniak, K.; Orhan, I.E.; Cordell, G.A.; Nabavi, S.M.; Budzyńska, B. Implication of coumarins towards central nervous system disorders. Pharmacol. Res., 2016, 103, 188-203.
[http://dx.doi.org/10.1016/j.phrs.2015.11.023] [PMID: 26657416]
[9]
Claudio Viegas-Junior Danuello, A.; da Silva Bolzani, V.; Barreiro, E.J.; Fraga, C.A. Molecular hybridization: a useful tool in the design of new drug prototypes. Curr. Med. Chem., 2007, 14(17), 1829-1852.
[http://dx.doi.org/10.2174/092986707781058805] [PMID: 17627520]
[10]
Mann, F.G.; Saunders, B.C. Practical Organic Chemistry, 4th ed.; Longman, 1960, pp. 307-308.
[11]
Daina, A.; Michielin, O.; Zoete, V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci. Rep., 2017, 7(1), 42717.
[http://dx.doi.org/10.1038/srep42717] [PMID: 28256516]
[12]
Pajouhesh, H.; Lenz, G.R. Medicinal chemical properties of successful central nervous system drugs. NeuroRx, 2005, 2(4), 541-553.
[http://dx.doi.org/10.1602/neurorx.2.4.541] [PMID: 16489364]
[13]
Winiwarter, S.; Ridderström, M.; Ungell, A.L.; Andersson, T.B.; Zamora, I. 5.22-Use of molecular descriptors for absorption, distribution, metabolism, and excretion predictions. Comprehensive Medicinal Chemistry II; John B. Taylor, David J. Triggle, 2007, 5, 531-554.
[14]
Prasanna, S.; Doerksen, R. Topological polar surface area: a useful descriptor in 2D-QSAR. Curr. Med. Chem., 2009, 16(1), 21-41.
[http://dx.doi.org/10.2174/092986709787002817] [PMID: 19149561]
[15]
Baell, J.; Congreve, M.; Leeson, P.; Abad-Zapatero, C. Ask the Experts: Past, present and future of the rule of five. Future Med. Chem., 2013, 5(7), 745-752.
[http://dx.doi.org/10.4155/fmc.13.61] [PMID: 23651089]
[16]
Verma, S.; Kumar, S.; Kumar, S. Design, synthesis, computational and biological evaluation of new benzodiazepines as CNS agents. Arab. J. Chem., 2020, 13(1), 863-874.
[http://dx.doi.org/10.1016/j.arabjc.2017.08.005]
[17]
Bourin, M. Animal models for screening anxiolytic-like drugs: a perspective. Dialogues Clin. Neurosci., 2015, 17(3), 295-303.
[http://dx.doi.org/10.31887/DCNS.2015.17.3/mbourin] [PMID: 26487810]
[18]
Fedotova, J.; Kubatka, P.; Büsselberg, D.; Shleikin, A.G.; Caprnda, M.; Dragasek, J.; Rodrigo, L.; Pohanka, M.; Gasparova, I.; Nosal, V.; Opatrilova, R.; Qaradakhi, T.; Zulli, A.; Kruzliak, P. Therapeutical strategies for anxiety and anxiety-like disorders using plant-derived natural compounds and plant extracts. Biomed. Pharmacother., 2017, 95, 437-446.
[http://dx.doi.org/10.1016/j.biopha.2017.08.107] [PMID: 28863384]
[19]
Pellow, S.; Chopin, P.; File, S.E.; Briley, M. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci. Methods, 1985, 14(3), 149-167.
[http://dx.doi.org/10.1016/0165-0270(85)90031-7] [PMID: 2864480]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy